Related Posts
- Quality of Life Assessment in IL-15RαFc N-803 + BCG for BCG-Unresponsive NMIBC Patients in QUILT 3.032
KEY TAKEAWAYS The QUILT 3.032 Phase 2/3 study assessed QoL of patients with BCG-unresponsive NMIBC…
- ORIENT-11 Phase 2 Trial Demonstrates Sintilimab in Non-squamous NSCLC Patients
KEY TAKEAWAYS ORIENT-11 was a phase 2 clinical trial that aimed to optimize the TIME…
- Phase III MabCute Study: Subcutaneous Rituximab in Patients with R/R Indolent Non-Hodgkin Lymphoma
KEY TAKEAWAYS Phase III MabCute trial evaluated the efficacy of extended maintenance with subcutaneous rituximab…